PhRMA Launches New Website to Showcase the Latest Data & Research on Innovation in the Biopharma Industry
The new website — the Innovation Hub — is accessible via www.Innovation.org and provides easy access to PhRMA resources related to the R&D process, the biopharmaceutical pipeline, and progress fighting diseases such as hepatitis C, Alzheimer’s, leukemia, cancer and HIV/AIDS.
This new resource features:
• New video on cumulative innovation: This video, “Cumulative steps, big gains for patients,” demonstrates how advances in treating debilitating diseases are usually the result of an accumulation of knowledge and research over time, rather than a single breakthrough in treatment.
• New infographic highlighting progress against hepatitis C: "New Hope for Patients with Hepatitis C,” highlights the value of new hepatitis C medicines that are curing 90% of patients and helping to prevent billions of dollars in hospitalizations and other medical costs to treat patients with the disease.
• Interactive timeline on great moments in medical innovation: Take a look at great moments in medical innovation — from the discovery of penicillin to the first polio vaccine to the mapping of the human genome.
• Slide show on progress against rheumatoid arthritis: See how medicines are improving the lives of patients with rheumatoid arthritis.
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...